Ascletis Pharma Inc - ESG Rating & Company Profile powered by AI
This report of Ascletis Pharma Inc is assembled by All Street Sevva using advanced NLP. Other companies in the rating industry group for Ascletis Pharma Inc are displayedin the table. The webpage contains a Q&A section on Ascletis Pharma Inc.
Ascletis Pharma Inc in the Pharmaceuticals industry gained a UN SDG ESG Transparency Score of 3.3; made up of an environmental score of 2.0, social score of 3.2 and governance score of 4.8.
3.3
Low ImpactEnvironmental
Social
Governance
![Detailed ESG Breakdown](/resource/detailed-esg.png?ts=1725478325797)
Peer Group Comparison
Rank | Company | SDG Transparency Score ⓘ | Performance |
---|---|---|---|
1 | Caladrius Biosciences Inc | 8.0 | High |
1 | Can Fite Biopharma Ltd | 8.0 | High |
... | ... | ... | |
1234 | Quanterix Corp | 3.4 | Medium |
1234 | X4 Pharmaceuticals Inc | 3.4 | Medium |
1253 | Ascletis Pharma Inc | 3.3 | Medium |
1253 | Calithera Biosciences Inc | 3.3 | Medium |
1253 | Cara Therapeutics Inc | 3.3 | Medium |
... | ... | ... | |
1970 | Zyden Gentec Ltd | 0.0 | Low |
1970 | iNtRON Biotechnology Inc | 0.0 | Low |
... | ... | ... |
![Peer Companies Benchmark](/resource/peer-benchmark-2.png?ts=1725478325797)
Frequently Asked Questions
Does Ascletis Pharma Inc have an accelerator or VC vehicle to help deliver innovation?
Does Ascletis Pharma Inc disclose current and historical energy intensity?
Does Ascletis Pharma Inc report the average age of the workforce?
Does Ascletis Pharma Inc reference operational or capital allocation in relation to climate change?
Does Ascletis Pharma Inc disclose its ethnicity pay gap?
Does Ascletis Pharma Inc disclose cybersecurity risks?
Does Ascletis Pharma Inc offer flexible work?
Does Ascletis Pharma Inc have a long term incentive (LTI) executive compensation plan based on a measure of return on capital?
Does Ascletis Pharma Inc disclose the number of employees in R&D functions?
Does Ascletis Pharma Inc conduct supply chain audits?
Does Ascletis Pharma Inc disclose incidents of non-compliance in relation to the health and safety impacts of products and services?
Is there a statment that there is no plan to expand their cement production? (for example: 'We have no current plans to add additional cement making capacity')
Does Ascletis Pharma Inc conduct 360 degree staff reviews?
Does Ascletis Pharma Inc disclose the individual responsible for D&I?
Does Ascletis Pharma Inc disclose current and historical air emissions?
Is there a statment that there is no plan to expand their coal usage? (for example: 'We have no current plans to add additional coal powered electricity generation')
Is executive remuneration linked to climate performance?
Does the Board describe its role in the oversight of climate-related risks and opportunities?
Does Ascletis Pharma Inc disclose current and / or historical scope 2 emissions?
Does Ascletis Pharma Inc disclose water use targets?
Does Ascletis Pharma Inc have careers partnerships with academic institutions?
Did Ascletis Pharma Inc have a product recall in the last two years?
Does Ascletis Pharma Inc disclose incidents of discrimination?
Does Ascletis Pharma Inc allow for Work Councils/Collective Agreements to be formed?
Has Ascletis Pharma Inc issued a profit warning in the past 24 months?
Does Ascletis Pharma Inc disclose parental leave metrics?
Does Ascletis Pharma Inc disclose climate scenario or pathway analysis?
Does Ascletis Pharma Inc disclose current and / or historical scope 1 emissions?
Are Operating Expesnses linked to emissions reduction?
Does Ascletis Pharma Inc disclose the pay ratio of women to men?
Does Ascletis Pharma Inc support suppliers with sustainability related research and development?
Does Ascletis Pharma Inc disclose the number of operations that have been subject to human rights reviews or human rights impact assessments?
Does Ascletis Pharma Inc reflect climate-related risks in its financial statements?
Is there a statment that there is no plan to expand their carbon intensite energy assets? (for example: 'We have no current plans to carry out further drilling for oil,')
Is Ascletis Pharma Inc involved in embryonic stem cell research?
Does Ascletis Pharma Inc disclose GHG and Air Emissions intensity?
Does Ascletis Pharma Inc disclose its waste policy?
Does Ascletis Pharma Inc report according to TCFD requirements?
Does Ascletis Pharma Inc disclose its policies for bribery, corruption, whistle-blower, conflict of interest?
Does Ascletis Pharma Inc disclose energy use targets?
Does Ascletis Pharma Inc disclose its Renewable Energy targets?
![Only Subscribers](/resource/reload.png)
Are emissions metrics verified by STBi?
![Only Subscribers](/resource/reload.png)
Does Ascletis Pharma Inc have a policy relating to cyber security?
Have a different question?
Potential Risks for Ascletis Pharma Inc
These potential risks are based on the size, segment and geographies of the company.
Ascletis Pharma Inc., a biotechnology company, engages in the research and development, manufacture, marketing, and sale of pharmaceutical products in Mainland China and internationally. The company offers Ritonavir oral tablet, a pharmacokinetic booster of various oral antiviral drugs targeting viral proteases and a component of the approved oral antiviral drug Paxlovid; ASCLEVIR and GANOVO for the treatment of Hepatitis C virus. It is also developing ASC22 for treating chronic hepatitis B (CHB) and human immunodeficiency virus functional cure; ASC42 for chronic hepatitis B functional cure; ASC10 and ASC11 to treat COVID-19; ASC40, ASC41, ASC42, ASC43F FDC, ASC44F FDC, and ASC45F FDC for non-alcoholic steatohepatitis; and ASC42 for the treatment of primary biliary cholangitis. In addition, the company is developing ASC40 to treat recurrent glioblastoma, drug resistant breast cancer, and KRAS mutant non-small cell lung cancer; ASC61 and ASC63 for advanced solid tumors; ASC60 to treat solid tumors; and ASC40 for the treatment of acne, Ascletis Pharma Inc. was founded in 2013 and is headquartered in Hangzhou, the People's Republic of China.